Radipharmaceuticals
Ended Awarded Last action
- Contract number
- 36C25225N0230
- Awardee
-
Jubilant Draximage Radiopharmacies, Inc. UEI EQ4VSLH8RC33
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $150,646
Award facts
- Contract value 23% obligated
-
- $150,646.01 Current, with exercised options
- $649,903.95 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Orlovista, FL 32811, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $423 | |
| Other Administrative Action | -$90,697 | |
| Original award | $240,920 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 12 (VISN 12), awarded a delivery order valued at $649,903.95 to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on February 1, 2025, for the supply of radiopharmaceuticals. This firm fixed-price delivery order, with an ultimate completion date of January 31, 2026, carries no set-aside designation and will be performed in Orlovista, Florida. Jubilant Radiopharma, a self-certified small disadvantaged business and subsidiary of Jubilant Life Sciences Limited, specializes in manufacturing and distributing radiopharmaceuticals and nuclear medicine products essential for diagnostic imaging, PET scans, cardiac imaging, and cancer treatment diagnostics across the VA healthcare system.
This delivery order is issued under one of Jubilant Radiopharma's existing Indefinite Delivery Vehicles with the VA, which provide the framework for the organization to efficiently procure critical medical isotopes and imaging agents across its nationwide network of facilities. The company has a demonstrated track record serving federal healthcare agencies, with prior contract awards ranging from approximately $30,000 to $1.7 million, and holds multiple IDV agreements with various VA regional networks valued up to $39.8 million. These radiopharmaceuticals—including products such as Gallium 68 Dotatate, iodine I-123, and technetium-99m—support nuclear medicine services that are vital to veteran patient care nationwide.
Quick answers
Who was awarded contract 36C25225N0230?
36C25225N0230 was awarded to Jubilant Draximage Radiopharmacies, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on February 1, 2025.
How much is contract 36C25225N0230 worth?
The government has obligated $150,646 on 36C25225N0230. Its potential value, with all options, is $649,904.
Is contract 36C25225N0230 an order under another contract?
Yes. 36C25225N0230 is a delivery order under 36C25225D0021, an indefinite delivery contract.
Was contract 36C25225N0230 competed?
The extent of competition for 36C25225N0230 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award